Ditchcarbon
  • Customers
  1. Organizations
  2. Wuxi Biologics
Public Profile
Medical Device Manufacturing
CN
updated 4 days ago

Wuxi Biologics

Company website

Wuxi Biologics, officially known as WuXi AppTec Co., Ltd., is a leading global contract research, development, and manufacturing organisation (CDMO) headquartered in Wuxi, China. Founded in 2010, the company has rapidly expanded its operations across major regions, including the United States and Europe, establishing itself as a key player in the biopharmaceutical industry. Specialising in biologics, Wuxi Biologics offers a comprehensive range of services, from cell line development to commercial manufacturing. Their unique integrated platform streamlines the drug development process, enabling clients to bring innovative therapies to market more efficiently. With a strong commitment to quality and innovation, Wuxi Biologics has achieved significant milestones, including numerous partnerships with leading pharmaceutical companies, solidifying its position as a trusted partner in the global biopharmaceutical landscape.

DitchCarbon Score

How does Wuxi Biologics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

50

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

26

Industry Benchmark

Wuxi Biologics's score of 50 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.

73%

Let us know if this data was useful to you

Wuxi Biologics's reported carbon emissions

In 2024, Wuxi Biologics reported total carbon emissions of approximately 198,654,000 kg CO2e, comprising 38,346,000 kg CO2e from Scope 1, 160,308,000 kg CO2e from Scope 2, and 24,470,000 kg CO2e from Scope 3 emissions. The Scope 3 emissions included significant contributions from employee commuting (about 19,176,000 kg CO2e) and fuel and energy-related activities (approximately 39,468,000 kg CO2e). For 2023, the company recorded total emissions of about 181,916,000 kg CO2e, with Scope 1 emissions at 32,687,000 kg CO2e and Scope 2 emissions at 149,229,000 kg CO2e. The Scope 3 emissions for that year were approximately 22,000,000 kg CO2e. Wuxi Biologics has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 greenhouse gas emission intensity by 50% by 2030, using 2020 as the base year. This target reflects the company's commitment to sustainability and aligns with its long-term goal of achieving net-zero emissions across all scopes by 2050, as confirmed by its Science Based Targets initiative (SBTi) commitments. The company has consistently disclosed its emissions data and reduction targets, demonstrating transparency and accountability in its climate strategy.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20202021202220232024
Scope 1
11,042,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
74,361,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
00,000,000
00,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Wuxi Biologics's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Wuxi Biologics is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Wuxi Biologics is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Ginkgo

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Bruker Cellular Analysis, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Catalent

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Evotec

DE
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

IQVIA Inc.

US
•
Research and development services (73)
Updated 7 days ago

Twist Bioscience Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250731.5
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy